2023 - Research.com Medicine in Canada Leader Award
2022 - Research.com Best Scientist Award
2022 - Research.com Medicine in Canada Leader Award
2014 - Canadian Medical Hall of Fame
Fellow of the American College of Cardiology (ACC)
Salim Yusuf mainly investigates Internal medicine, Cardiology, Myocardial infarction, Surgery and Stroke. Many of his studies on Internal medicine involve topics that are commonly interrelated, such as Diabetes mellitus. His Cardiology course of study focuses on Ramipril and Telmisartan.
His Myocardial infarction research is multidisciplinary, incorporating elements of Perioperative and Confidence interval. His Surgery study integrates concerns from other disciplines, such as Angiotensin II, Placebo and Risk factor. In his study, which falls under the umbrella issue of Stroke, Bradycardia is strongly linked to Atrial fibrillation.
Salim Yusuf mainly focuses on Internal medicine, Cardiology, Myocardial infarction, Stroke and Surgery. His study looks at the relationship between Internal medicine and fields such as Diabetes mellitus, as well as how they intersect with chemical problems. In the subject of general Cardiology, his work in Ejection fraction is often linked to In patient, thereby combining diverse domains of study.
His research in Myocardial infarction intersects with topics in Odds ratio, Placebo and Coronary artery disease. The concepts of his Stroke study are interwoven with issues in Aspirin and Epidemiology. Salim Yusuf has included themes like Anesthesia and Clinical trial in his Randomized controlled trial study.
His primary areas of investigation include Internal medicine, Stroke, Cardiology, Myocardial infarction and Disease. His work in Aspirin, Hazard ratio, Atrial fibrillation, Heart failure and Randomized controlled trial are all subfields of Internal medicine research. The various areas that Salim Yusuf examines in his Stroke study include Clinical trial, Statin, Blood pressure, Developing country and Cardiac surgery.
His Cardiology study incorporates themes from Diabetes mellitus, Framingham Risk Score and Montreal Cognitive Assessment. His studies deal with areas such as Regimen and Anesthesia as well as Myocardial infarction. His work carried out in the field of Disease brings together such families of science as Prospective cohort study, Epidemiology, Health care and Risk factor.
The scientist’s investigation covers issues in Internal medicine, Stroke, Cardiology, Hazard ratio and Myocardial infarction. His Internal medicine and Aspirin, Randomized controlled trial, Heart failure, Coronary artery disease and Atrial fibrillation investigations all form part of his Internal medicine research activities. Salim Yusuf interconnects Genetics, Clinical trial, Family medicine, Dabigatran and Evidence-based medicine in the investigation of issues within Stroke.
His work on Revised Cardiac Risk Index as part of his general Cardiology study is frequently connected to In patient, thereby bridging the divide between different branches of science. His Hazard ratio research incorporates themes from Randomization, Prospective cohort study, Proportional hazards model and Cohort study. His work deals with themes such as Regimen, Placebo and Risk assessment, which intersect with Myocardial infarction.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study
Salim Yusuf;Steven Hawken;Stephanie Ôunpuu;Tony Dans.
The Lancet (2004)
MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20536 high-risk individuals: a randomised placebo-controlled trial. Commentary
Salim Yusuf.
The Lancet (2002)
Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation.
S Yusuf;F Zhao;S R Mehta;S Chrolavicius.
The New England Journal of Medicine (2001)
Effects of an angiotensin-converting -enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients
S Yusuf;P Sleight;J Pogue.
The New England Journal of Medicine (2000)
Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure.
Solvd Investigators;Salim Yusuf;Bertram Pitt;Clarence E Davis.
The New England Journal of Medicine (1991)
COLLABORATIVE OVERVIEW OF RANDOMIZED TRIALS OF ANTIPLATELET THERAPY .1. PREVENTION OF DEATH, MYOCARDIAL-INFARCTION, AND STROKE BY PROLONGED ANTIPLATELET THERAPY IN VARIOUS CATEGORIES OF PATIENTS
R Altman;L Carreras;R Diaz;E Figueroa.
BMJ (1994)
Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study.
Shamir R. Mehta;Salim Yusuf;Ron J. G. Peters;Michel E. Bertrand.
The Lancet (2001)
Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions.
Solvd Investigators;Yusuf S;Pitt B;Davis Ce.
The New England Journal of Medicine (1992)
Global Burden of Cardiovascular Diseases Part I: General Considerations, the Epidemiologic Transition, Risk Factors, and Impact of Urbanization
Salim Yusuf;Srinath Reddy;Stephanie Ôunpuu;Sonia Anand.
Circulation (2001)
Risk factors for ischaemic and intracerebral haemorrhagic stroke in 22 countries (the INTERSTROKE study): a case-control study
Martin J O'Donnell;Martin J O'Donnell;Denis Xavier;Lisheng Liu;Hongye Zhang.
The Lancet (2010)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
McMaster University
McMaster University
Population Health Research Institute
Population Health Research Institute
Population Health Research Institute
Population Health Research Institute
Uppsala University
McMaster University
Population Health Research Institute
University of South Africa
Kessler Foundation
Institut National de la Recherche Scientifique
Toyota Motor Corporation (Japan)
Technical University of Denmark
Spanish National Research Council
University of Lausanne
University of Miami
Mayo Clinic
Hannover Medical School
The Francis Crick Institute
Brown University
Kyoto University
University of Exeter
Newcastle University
Uppsala University
World Bank